Related Experiment Video
Updated: Aug 12, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and
Addolorata Corrado1, Natalia Mansueto1, Michele Correale2
1Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia, Viale Pinto 1, Foggia, Italy.
Insights
Systemic Sclerosis patients show endothelial dysfunction, indicated by lower Flow Mediated Dilation (FMD) and higher vascular markers. These FMD impairments correlate with disease severity and complications, highlighting FMD and biomarkers for assessing SSc vasculopathy.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Vascular Biology
Background:
- Endothelial dysfunction is central to vascular damage in Systemic Sclerosis (SSc).
- Understanding SSc pathophysiology requires assessing endothelial function and related biomarkers.
- Microvascular and macrovascular complications are significant in SSc patients.
Purpose of the Study:
- To evaluate endothelial dysfunction in SSc using Flow Mediated Dilation (FMD).
- To measure serum levels of key endothelial dysfunction markers: Vascular Endothelial Growth Factor (VEGF), Vascular Cell Adhesion Molecule-1 (VCAM-1), and angiopoietin-2.
- To correlate macrovascular damage with clinical findings and microvascular patterns in SSc.
Main Methods:
- Recruited 57 SSc patients and 37 healthy controls.
- Performed radial artery FMD testing and Nailfold Video-Capillaroscopy.
- Assessed serum levels of VEGF, VCAM-1, and angiopoietin-2.
Main Results:
- SSc patients exhibited significantly lower FMD and higher time to maximal FMD response compared to controls.
- Serum levels of VEGF, VCAM-1, and angiopoietin-2 were significantly elevated in SSc patients.
- Impaired FMD correlated with disease duration, pulmonary arterial hypertension, digital ulcers, and microvascular damage. VEGF and angiopoietin-2 were higher in patients with digital ulcers and pulmonary arterial hypertension.
Conclusions:
- Flow Mediated Dilation (FMD) ultrasound and circulating endothelial dysfunction markers show potential as biomarkers for vasculopathy in SSc.
- These assessments can aid in evaluating vascular injury in Systemic Sclerosis patients.
- Integrating FMD and biomarker analysis offers a comprehensive approach to understanding SSc vascular complications.
Aim:
Endothelial dysfunction represents a key feature of the pathological process underlying micro and macro-vascular damage in Systemic Sclerosis (SSc). This study aims to improve knowledge of the physiopathology of vascular damage in SSc through the assessment of the endothelial dysfunction by Flow Mediated Dilation (FMD) and serum levels of circulating endothelial dysfunction markers and the correlation of macrovascular damage with clinical findings and microvascular capillaroscopic patterns.
Methods:
57 SSc patients and 37 healthy subjects were recruited. All included subjects underwent radial artery FMD test and Nailfold Video-Capillaroscopy; serum levels of Vascular Endothelial Growth Factor (VEGF), Vascular Cell Adhesion Molecule-1 (VCAM-1) and angiopoietin-2 were evaluated.
Results:
Compared to healthy subjects, in SSc patients lower FMD and higher time needed to obtain the maximal FMD responsewere observed, whereas serum levels of VEGF, VCAM-1, and angiopoietin-2 were significantly higher. The impairment of FMD values was associated with disease duration, pulmonary arterial hypertension, and digital ulcers and correlates with greater microvascular damage evaluated by Nailfold Video-Capillaroscopy… An inverse relationship between VEGF, angiopoietin-2, VCAM-1 levels and FMD was observed, but only VEGF and angiopoietin-2 were significantly higher in patients with digital ulcers and pulmonary arterial hypertension.
Conclusions:
FMD ultrasound test and circulating levels of endothelial dysfuncion markers could be useful as biomarkers of vasculopathy and could be a helpful tool in the overall assessment of vascular injury in Systemic Sclerosis patients.
Related Concept Videos
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

